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Screening for Vancomycin Intermediate -Resistant Staphylococcus aureus among Clinical Isolates of MRSA
Staphylococcus aureus that are intermediate-resistant to of ≥ 4 µg/mL upon selection with vancomycin, with stability vancomycin (VISA) with MIC 8 µg/mL were first reported in of the strain pesisting beyond 9 days in a drug-free medium. Japan in 1996 1 and continue to be reported from various parts If confluent growth of cells was seen within 24 hours, it was Resistance is mainly due to overuse and a potential VRSA.
2 improper use of vancomycin and due to cross resistance from other glycopeptides like teicoplanin. As documented evidence Out of 224 isolates, 92.4% were from adults and 7.6% from of VISA in India are very few, 3 we intended to find out the children, 88.8% were from wards and 11.2% from intensive care occurrence of VISA in clinical methicillin resistant units (ICUs). All the 224 isolates were sensitive to vancomycin Staphylococcus aureus (MRSA) isolates of our hospital.
(100%) by disc diffusion method. All the isolates showed no turbidity even in the tube containing 2 µg/mL of vancomycin A total of 224 MRSA isolates from wound swabs, frank by broth dilution method. Of the 50 isolates tested for hetero pus, blood, urine, respiratory samples, fluids, intravascular VISA, 3 (6%) showed one colony each in BHIA incorporated devices, Foley's catheters and other swabs received in with 4 µg/mL vancomycin. These three strains were further Microbiology Department of LTMG Hospital, Mumbai, were processed for detection of MIC by broth dilution method with studied during a 12-month period for vancomycin concentrations of vancomycin being 2 µg/mL, 4 µg/mL and 8 susceptibility by disc diffusion method of Kirby-Bauer and µg/mL. None of the three showed any turbidity in the broth MIC by broth dilution method. For MIC, 2-fold dilutions of dilutions. vancomycin (Alkem Laboratories Ltd.) were prepared in supplemented Mueller Hinton Broth (SMHB), ranging from 2 Appearance of VISA since 1996 became a grave concern µg/mL to 64 µg/mL. To each tube 1 mL of actively growing to the clinicians.
1 This not only revealed the therapeutic failure suspension of MRSA isolate (matched with 0.5 McFarland of vancomycin against MRSA infections, but also brought out standard) and 1 mL of the antibiotic dilution were added and the fact that there is no effective alternate therapy for the same. incubated at 37 o C for 18-24 hours. Staphylococcus aureus Due to the difficulty in treating the patients with VISA, NCTC 6571 was used as reference strain. MIC was calculated as the highest dilution of the drug inhibiting the growth and showing no turbidity. Growth in tubes ≥ 4 µg/mL was taken as VISA. Growth in tubes ≥ 32 µg/mL was taken as vancomycin resistant Staphylococcus aureus (VRSA). 4 Fifty MRSA isolates were also screened for hetero-VISA. 2 Hetero-VISA status was confirmed if the strain produced subclone (s) with a vancomycin MIC screening of all MRSA isolates for detection of VISA is really essential in all hospital setups. In the present study, vancomycin sensitivity was 100% by Kirby-Bauer method and MIC of vancomycin of all the 224 MRSA isolates were < 2 µ/ mL. Thus none of our isolates were VISA. Assadullah et al from Srinagar has reported vancomycin MIC 8 µg/mL in 15% MRSA isolates and 16 µg/mL in 3.3% cases. 3 In 1997, Japanese hospitals described heterogenous intermediate-resistance to vancomycin in clinical isolates of Staphylococcus aureus (Hetero-VISA) with an incidence of 9.3% in university hospitals and 1.3% in non-university hospitals. Correspondence hetero-VISA strains in this study was 6% (3/50). On repeating vancomycin MIC of these colonies, none of the three grew even in broth containing 2 µg/mL of vancomycin, therefore they were not confirmed hetero-VISA. Though no VISA was encountered in this study, reduction of overuse and misuse of antibiotics will decrease the risk of emergence of MRSA and also restriction of vancomycin use, to prevent spread of VISA in India. This study will help in providing guidance for choosing effective therapy against MRSA isolates. Antibiotics should be administered only on clinical suspicion of sepsis. Perioperative short-term antibiotic therapy can be given. Strict hand washing before and after handling each patient and restriction of movements of personnel within the ICUs and wards should be implemented. The high rise of morbidity and
